Ivan Tretyakov

With more than 13 years of experience working in both high-tech companies and management consulting and having worked in more than 10 countries across Europe, Africa, Middle East, and Latin America, Ivan Tretyakov has specialised in using data insights to advantage when driving profitable revenue growth through strategic decision making processes.

Harshit Bhardwaj

Harshit specialises in New Product Development and Innovation Management and has developed a strong understanding of the international market.   A leading expert in product line scoping and encompassing strategy and roadmapping for a successful product launch while minimising risk and boosting opportunity.

Camille Vidal

Experienced beverage industry game changer with a demonstrated history of working in the wine and spirits industry and an advocate for low and no and mindful drinking. Skilled in Marketing Management, Shopper Marketing, Sales and Marketing, and Fast-Moving Consumer Goods (FMCG).

Marcus Thieme

With over 16 years’ experience in various executive positions at Mast-Jägermeister, Marcus Thieme now brings a wealth of experience that fits perfectly with BrewDog’s aspirations and ambitious expansion plans. The focus of his responsibilities are to drive growth in key international markets pushing the company forward into strong positions supported by his strategical decisions and strong background in sales and marketing.

Ryan Tubbs

Co-Founder, Clinical Research Innovation Hub, Microsoft Corporation

The Clinical Research Innovation Hub (CRIH) is the first industry focused internal startup in Microsoft. Innovation hubs are engines that allow Microsoft to focus on pressing industry problems by combining the speed, agility and autonomy of a startup with resources available to a large enterprise. CRIH analyzes problems deeply through interviews and experiments, then rapidly builds solutions alongside Microsoft customers and partners.

Ryan is responsible for the operations of the innovation hub, for the management of the portfolio, and for creating the conditions for agile and open innovation. CRIH is enabling Microsoft and its partners to conceptualize, incubate, and ultimately deliver the technology innovations that will drive the adoption of new clinical research paradigms.

Ryan has been with Microsoft for 12 years. Prior to his current role he served as a Chief Transformation Officer for the US subsidiary, responsible for designing and executing change management strategies for transforming sales, marketing, and services operations for the $33B business.

Before joining Microsoft, Ryan was the CIO for the City of Chicago city council, responsible for implementing IT policies and data security protocols to protect the integrity of sensitive citizen and employee data. He partnered with Microsoft and implementation partners to modernize and transform dozens of legacy systems, enabling greater transparency in government and more citizen-centric applications.

Ryan holds a Bachelor of Science in Chemical Engineering from North Carolina State University and a Master of Business Administration from Duke University (The Fuqua School of Business).

Paul Slater

Co-Founder, Clinical Research Innovation Hub, Microsoft Corporation

The Clinical Research Innovation Hub (CRIH) is the first industry focused internal startup in Microsoft. Innovation hubs are engines that allow Microsoft to focus on pressing industry problems by combining the speed, agility and autonomy of a startup with resources available to a large enterprise. CRIH analyzes problems deeply through interviews and experiments, then rapidly builds solutions alongside Microsoft customers and partners.

Paul is responsible for the strategy of the innovation hub, for establishing a target technology architecture for clinical research, and for building partnerships within and outside of Microsoft that realize the transformation vision. Microsoft and its partners are building solutions that will allow end-to-end digitization of the study, maximize the value of research data and ensure patient needs are met as research modernizes.

Paul has been at Microsoft for 8 years. Prior to his current role he worked as Worldwide Director of Industry Strategy for Life Sciences, and as a Director of Enterprise Architecture, focused on developing incubation solutions in the life sciences industry and multiple other industries, including energy production, discrete manufacturing, financial services and education.

Before joining Microsoft, Paul was a Senior Enterprise Architect at Weyerhaeuser – a global forest products company. He was responsible for the overall technology architecture of the organization, developed Weyerhaeuser’s virtualization, cloud and security strategies, and defined a target architecture for shared services across multiple lines of business.

He is the author or co-author of multiple papers and books on both health and technology issues. He has delivered keynote addresses at multiple conferences in the United States and Europe, including CDISC Interchange, BME Global Pharma Supply Chain Congress, Parexel Horizons, and the Society for Clinical Data Management. He holds a Bachelor of Science (Hons) in Mathematics from King’s College. London.

Ivan Chan

Dr Ivan S.F. Chan has 20+ years of experience in pharmaceutical industry. He is Vice President and Head of Statistical Sciences, Data & Statistical Sciences, at AbbVie Inc. In this capacity, he leads the statistics organization supporting discovery, biomarker development, clinical development and global medical affairs for all therapeutic areas. Prior to joining AbbVie, Ivan was Executive Director of Biostatistics at Merck Research Laboratories.

 

Ivan is a Fellow of the American Statistical Association (ASA) and a Fellow of the Society for Clinical Trials (SCT). Ivan serves as Executive Director of the International Society for Biopharmaceutical Statistics (ISBS). He has 80+ publications in statistical and clinical journals.

Michael Sunil Roberts

Successful Business Development professional with vast experience in innovation, brand and franchise management, key accounts, intrapreneuring, strategic plans, corporate submissions, M&A and sustainability.

Iñigo Madariaga

With more than 20 years experience in the refreshment sector and ex general secretary of Europe Pepsico, Iñigo Madariaga is now driving the growth behind green cola in Spain, the greener beverage alternative. Experienced in the beverage industry, Madariaga believes in the success of a product that offers solutions to consumer concerns, without compromising on flavour.

Joaquim Quoden

An expert in sustainability and packaging, in combination with a strong international industry law background, Joaquim Quoden has dedicated his work to the field of producer responsibility especially with regard to packaging since November 1992. With a senior role in the following organisations; EPR, EXPRA, DSD, Green Dot, PRO EUROPE, Joaquim is knowledgeable in sustainability regulations and packaging advancements.